Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen in Cryptococcal Meningitis
NCT03112031Phase 2Completed
- Sponsor
- Oxford University Clinical Research Unit
- Start
- Oct 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tamoxifen in cryptococcal meningitis (2 arms), sponsored by Oxford University Clinical Research Unit. Primary endpoint: Early Fungicidal Activity at 2 weeks. Started Oct 2017; status: completed.
02
Drugs
tamoxifen
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT03112031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112031.